Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03286296
Title LZM009 to Treat Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Livzon Pharmaceutical Group Inc.
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

LZM009

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
START Midwest Grand Rapids Michigan 49546 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field